Since Bmi‐1's major role is in remodeling the tumor niche to support the plasticity of GSCs rather than initiating the tumorous mass, we propose that silencing Bmi‐1 should be along with other treatment(s) to obtain the maximum benefit. This evidence concerns the gene BMI1 and neoplasm.